HIGH-GRADE SEROUS OVARIAN CARCINOMA (HGSOC)
Clinical trials for HIGH-GRADE SEROUS OVARIAN CARCINOMA (HGSOC) explained in plain language.
Never miss a new study
Get alerted when new HIGH-GRADE SEROUS OVARIAN CARCINOMA (HGSOC) trials appear
Sign up with your email to follow new studies for HIGH-GRADE SEROUS OVARIAN CARCINOMA (HGSOC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Swiss trial aims to match ovarian cancer patients with better treatments
Disease control Recruiting nowThis Swiss study is testing whether personalized treatment recommendations can help patients with a specific type of ovarian cancer. Doctors will analyze each patient's tumor to suggest the most suitable drugs, which may differ from standard chemotherapy. The trial will compare o…
Matched conditions: HIGH-GRADE SEROUS OVARIAN CARCINOMA (HGSOC)
Phase: NA • Sponsor: Swiss GO Trial Group • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Could a breast cancer pill keep ovarian cancer at bay?
Disease control Recruiting nowThis large Phase 3 trial is testing whether adding the drug letrozole to standard maintenance therapy helps prevent ovarian cancer from coming back. It will involve 540 women with ER-positive ovarian, fallopian tube, or peritoneal cancer who have completed initial surgery and che…
Matched conditions: HIGH-GRADE SEROUS OVARIAN CARCINOMA (HGSOC)
Phase: PHASE3 • Sponsor: Swiss GO Trial Group • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
First patients to receive experimental cancer drug in new trial
Disease control Recruiting nowThis is the first human study of an experimental drug called BMS-986463 for people with advanced ovarian, uterine, or lung cancers. The main goal is to find safe dose levels and see how the body processes the drug. Researchers will enroll about 240 participants to monitor side ef…
Matched conditions: HIGH-GRADE SEROUS OVARIAN CARCINOMA (HGSOC)
Phase: PHASE1 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC